The purpose of this registry is to evaluate the safety and efficacy of RIC for patients with symptomatic intracranial atherosclerotic stenosis (sICAS) undergoing endovascular therapy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
The presence of ≥1 new brain lesions on DWI within 48 hours after endovascular stenting
Timeframe: 48 hours
Incidence of clinical adverse events within 12 months after endovascular stenting
Timeframe: 12 months